The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of BrightSpring Health Services Inc (NASDAQ: BTSG) closed at $18.13 in the last session, down -1.15% from day before closing price of $18.34. In other words, the price has decreased by -$1.15 from its previous closing price. On the day, 1.38 million shares were traded. BTSG stock price reached its highest trading level at $18.46 during the session, while it also had its lowest trading level at $17.88.
Ratios:
We take a closer look at BTSG’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 1.76 whereas as Long-Term Debt/Eq ratio is at 1.68.
On June 21, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.BTIG Research initiated its Buy rating on June 21, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Walgreens Boots Alliance, Inc. sold 12,000,000 shares for $21.16 per share. The transaction valued at 253,920,000 led to the insider holds 11,239,996 shares of the business.
Walgreen Co. bought 12,000,000 shares of BTSG for $265,800,000 on Feb 18 ’25. On Sep 11 ’24, another insider, Walgreens Boots Alliance, Inc., who serves as the 10% Owner of the company, sold 11,619,998 shares for $11.13 each. As a result, the insider received 129,330,578 and left with 23,239,996 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTSG now has a Market Capitalization of 3172278528 and an Enterprise Value of 6009084928. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 0.533 whereas that against EBITDA is 11.055.
Stock Price History:
The Beta on a monthly basis for BTSG is 2.10, which has changed by 0.88657653 over the last 52 weeks, in comparison to a change of 0.08190584 over the same period for the S&P500. Over the past 52 weeks, BTSG has reached a high of $24.82, while it has fallen to a 52-week low of $8.86. The 50-Day Moving Average of the stock is -9.14%, while the 200-Day Moving Average is calculated to be 14.54%.
Shares Statistics:
According to the various share statistics, BTSG traded on average about 1.48M shares per day over the past 3-months and 1682100 shares per day over the past 10 days. A total of 174.25M shares are outstanding, with a floating share count of 68.17M. Insiders hold about 61.04% of the company’s shares, while institutions hold 46.19% stake in the company. Shares short for BTSG as of 1740700800 were 9551208 with a Short Ratio of 6.43, compared to 1738281600 on 9306476. Therefore, it implies a Short% of Shares Outstanding of 9551208 and a Short% of Float of 17.41.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are eagerly awaiting the insights provided by 10.0 analysts currently analyzing and rating the stock of BrightSpring Health Services Inc (BTSG).The consensus estimate for the next quarter is $0.12, with high estimates of $0.17 and low estimates of $0.07.
Analysts are recommending an EPS of between $0.69 and $0.43 for the fiscal current year, implying an average EPS of $0.56. EPS for the following year is $0.8, with 11.0 analysts recommending between $0.99 and $0.65.
Revenue Estimates
According to 11 analysts, the current quarter’s revenue is expected to be $2.74B. It ranges from a high estimate of $3.05B to a low estimate of $2.67B. As of the current estimate, BrightSpring Health Services Inc’s year-ago sales were $2.58BFor the next quarter, 11 analysts are estimating revenue of $2.9B. There is a high estimate of $3.22B for the next quarter, whereas the lowest estimate is $2.8B.
A total of 13 analysts have provided revenue estimates for BTSG’s current fiscal year. The highest revenue estimate was $13.06B, while the lowest revenue estimate was $11.77B, resulting in an average revenue estimate of $11.97B. In the same quarter a year ago, actual revenue was $11.27BBased on 13 analysts’ estimates, the company’s revenue will be $13.32B in the next fiscal year. The high estimate is $14.16B and the low estimate is $12.72B.
